Keyphrases
10-year Follow-up
25%
5-year Follow-up
24%
Aarhus
5%
Alcohol Consumption
6%
All-cause Mortality
5%
Astra
5%
Atrial Fibrillation
25%
Behavior Change
25%
Between-group
5%
Between-group Difference
5%
Binomial Regression Model
6%
Blood Cholesterol
5%
Blood Pressure
5%
Cambridge
13%
Cardiovascular Events
15%
Cardiovascular Morbidity
5%
Cardiovascular Mortality
10%
Cardiovascular Outcomes
10%
Cardiovascular Risk
15%
Care Groups
15%
Change in Weight
6%
Cluster Randomized Trial
25%
Community-based
25%
Composite Outcome
5%
Composite Score
8%
Cox Proportional Hazards Regression
5%
Denmark
18%
Diabetes
10%
Diabetes Diagnosis
6%
Diabetes Management
10%
Diabetes Remission
12%
Diabetes Treatment Satisfaction
25%
Diabetes Treatment Satisfaction Questionnaire
17%
EQ-5D
17%
Europe
25%
Evaluation Technology
5%
First Year
12%
Fixed Effects
8%
General Practice
29%
GlaxoSmithKline
5%
Glycaemia
5%
Hazard Ratio
10%
HbA1c Levels
6%
Health Board
5%
Health Sciences
5%
Health Status
25%
Health Surveys
17%
Health Technology Assessment
5%
HemoCue
5%
Hemoglobin A1c (HbA1c)
5%
Intensive Care Medicine
46%
Intention-to-treat Principle
5%
Leicester
13%
Log-binomial Regression
6%
Lost to Follow-up
5%
Medical Research Council
10%
Merck
5%
Metaanalysis
8%
Mixed-effects Model
8%
Multifactorial Treatment
35%
Multiple Risk Factors
5%
National Boards
5%
National Health Service
5%
National Institute for Health Research
5%
Netherlands
18%
New-onset Diabetes
6%
No Significant Difference
5%
Nonfatal Myocardial Infarction
5%
Nonfatal Stroke
5%
Novo Nordisk
10%
Patient-reported Outcomes
25%
Patient-Reported Outcomes Measurement Information System (PROMIS)
17%
Pfizer
5%
Physical Activity
6%
Plasma Vitamin C
6%
Population-based
5%
Post-intervention Follow-up
5%
Primary Care
25%
Professional-patient Relations
8%
Prospective Cohort Study
25%
Quality of Life
25%
Quality of Life Questionnaire
17%
Remission
25%
Renal Outcome
5%
Revascularization
5%
Risk Ratio
6%
Routine Care
46%
Screen-detected
25%
Screening Program
5%
SERVUS
5%
Stepwise Screening
11%
Strategic Research
5%
Traumatic Amputation
5%
Treatment Group
15%
Treatment Risk
10%
Type 2 Diabetes Mellitus (T2DM)
77%
Type 2 Diabetes Prevention
8%
Type 2 Diabetic Patients
5%
UK Department of Health
5%
UK National Health Service
5%
University Research
5%
Weight Change
6%
Weight Loss
25%
Wellcome Trust
5%
Medicine and Dentistry
Alcohol Consumption
6%
All Cause Mortality
10%
Arm
5%
Ascorbic Acid
6%
Atrial Fibrillation
25%
Behavioral Change
25%
Body Mass Index
5%
Body Weight
5%
Body Weight Change
32%
Cardiovascular Disease
40%
Cardiovascular Mortality
30%
Cardiovascular Risk
12%
Cardiovascular System
25%
Care Group
12%
Cluster Randomized Trial
25%
Diabetes
100%
Diabetes Mellitus
25%
Drug Therapy
8%
General Medicine
25%
Glycon
25%
Group Therapy
15%
Hazard Ratio
8%
Health Status
15%
Health Survey
10%
Hemoglobin A1c
13%
Hyperglycemia
25%
Maturity Onset Diabetes of the Young
79%
Medical Record
5%
Medical Research
8%
Meta-Analysis
5%
National Health Service
8%
Physical Activity
6%
Placebo
14%
Primary Health Care
28%
Prospective Cohort Study
25%
Quality of Life
28%
Randomized Controlled Trial
25%
Self Report
12%
Nursing and Health Professions
All Cause Mortality
6%
Alprenolol
6%
Biomedical Technology Assessment
6%
Blood Pressure
6%
Cardiovascular Mortality
6%
Cardiovascular Risk
19%
Care Group
19%
Clinical Audit
10%
General Practice
30%
Glucose Blood Level
6%
Group Therapy
19%
Hazard Ratio
12%
Health Status
15%
Health Survey
10%
Heart Infarction
6%
Hemoglobin A1c
6%
Hyperglycemia
25%
Intention to Treat Analysis
6%
Meta Analysis
5%
Non Insulin Dependent Diabetes Mellitus
77%
Patient with Type 2 Diabetes
10%
Patient-Reported Outcome
25%
Physician
25%
Post Hoc Analysis
6%
Primary Medical Care
51%
Quality of Life
25%
Randomization
6%
Revascularization
6%
Screening
6%
Socialized Medicine
12%
Traumatic Amputation
6%